#1 Clinical Trials Search in Europe

Budesonide

Budesonide, a corticosteroid medication, has been the subject of numerous clinical trials investigating its effectiveness and safety in treating various conditions. This article explores the use of budesonide in clinical studies for asthma, allergic rhinitis, and Crohn’s disease. We’ll examine different formulations, dosages, and administration methods to understand how this drug performs in treating these conditions across different age groups.

Table of Contents

What is Budesonide?

Budesonide is a medication that belongs to a class of drugs called corticosteroids. It is used to treat various inflammatory conditions in the body. Budesonide works by reducing inflammation and suppressing the immune system’s response in affected areas[1].

This medication is known by several brand names, including:

  • Pulmicort (for respiratory conditions)[2]
  • Entocort (for gastrointestinal conditions)[6]
  • Uceris (another form for gastrointestinal conditions)[8]
  • Symbicort (a combination medication with formoterol)[1]

What Conditions Does Budesonide Treat?

Budesonide is used to treat several conditions, including:

  1. Asthma: It helps control and prevent symptoms of asthma, including wheezing, shortness of breath, and chest tightness[2][5].
  2. Exercise-Induced Bronchoconstriction: This is a type of asthma triggered by physical activity. Budesonide can help prevent airway narrowing during exercise[3].
  3. Allergic Rhinitis: Also known as hay fever, this condition causes symptoms like sneezing, runny nose, and nasal congestion. Budesonide nasal sprays can help relieve these symptoms[5].
  4. Crohn’s Disease: This is an inflammatory bowel disease. Budesonide can help reduce inflammation in the digestive tract[6][7].
  5. Bronchiolitis Obliterans: This is a rare lung disease that can occur after stem cell transplantation. Budesonide, when combined with other medications, may help manage symptoms[1].

How Does Budesonide Work?

Budesonide works by reducing inflammation in the body. When you have conditions like asthma or Crohn’s disease, certain areas of your body become inflamed. This inflammation can cause symptoms like difficulty breathing or abdominal pain.

When you take budesonide, it enters the cells in the inflamed areas and helps to decrease the production of substances that cause inflammation. By reducing inflammation, budesonide helps to relieve symptoms and prevent flare-ups of the condition[1][2].

Forms and Dosages of Budesonide

Budesonide comes in several forms, depending on the condition being treated:

  • Inhaler: For asthma and other respiratory conditions. It may be a dry powder inhaler (like Pulmicort Turbuhaler) or a metered-dose inhaler[2][5].
  • Nebulizer solution: Also for respiratory conditions, this liquid form (Pulmicort Respules) is turned into a mist and inhaled using a nebulizer machine[4].
  • Nasal spray: For allergic rhinitis[5].
  • Oral capsules: For Crohn’s disease (Entocort EC)[6][7].
  • Extended-release tablets: Another form for gastrointestinal conditions (Uceris)[8].

Dosages vary depending on the condition being treated, the severity of the condition, and the patient’s age. Always follow your doctor’s instructions or the directions on the label[2][6].

Effectiveness of Budesonide

Clinical trials have shown budesonide to be effective in treating various conditions:

  • In asthma patients, budesonide has been shown to improve lung function and reduce symptoms[2][5].
  • For exercise-induced bronchoconstriction, budesonide can help prevent the narrowing of airways during physical activity[3].
  • In patients with allergic rhinitis, budesonide nasal spray has been effective in reducing nasal symptoms[5].
  • For Crohn’s disease, budesonide has shown effectiveness in inducing remission and maintaining symptom control[6][7].

Potential Side Effects

Like all medications, budesonide can cause side effects, although not everyone experiences them. Some potential side effects include:

  • Throat irritation or hoarseness (when using inhalers)[2]
  • Nasal irritation or nosebleeds (with nasal sprays)[5]
  • Headache
  • Nausea
  • Respiratory infections

Long-term use of high doses of budesonide may lead to more serious side effects, such as weakened immune system or adrenal suppression. Always discuss potential risks with your healthcare provider[1][6].

Special Considerations

There are some important things to keep in mind when using budesonide:

  • If you’re using an inhaler for asthma, it’s important to use it regularly as prescribed, even if you’re not experiencing symptoms. This helps prevent asthma attacks[2].
  • Budesonide is not a rescue medication. It won’t provide immediate relief during an asthma attack. Always have a quick-relief inhaler available[2].
  • If you’re taking budesonide for Crohn’s disease, don’t stop taking it suddenly without talking to your doctor. Your dose may need to be reduced gradually[6].
  • Budesonide can affect growth in children. If your child is using this medication, their height should be regularly monitored[4].
  • Always inform your healthcare provider about all medications you’re taking, including over-the-counter drugs and supplements, as they may interact with budesonide[8].
Condition Formulations Age Groups Key Outcomes Measured
Asthma Pulmicort Respules, Pulmicort Turbuhaler Adults, Adolescents (12+ years), Children (2-8 years) Lung function (PEF, FEV1), Symptom scores, Rescue medication use
Allergic Rhinitis Noex, Budecort Aqua, Rhinocort Aqua Adults, Children (2-5 years) Nasal Index Score (NIS), Symptom scores
Crohn’s Disease Entocort EC Children and Adolescents (5-17 years) Pediatric Crohn’s Disease Activity Index, Quality of Life scores
Bioequivalence Study Ekmasonid, Uceris (extended-release tablets) Healthy Adults Pharmacokinetic parameters (Cmax, AUC, Tmax)

FAQ

  • What conditions is budesonide used to treat in these clinical trials? The clinical trials discussed in this article investigate the use of budesonide for treating asthma, allergic rhinitis, and Crohn's disease in both adults and children.
  • What are the different formulations of budesonide used in these studies? The studies use various formulations of budesonide, including inhalation powders (Pulmicort Turbuhaler), nebulized suspensions (Pulmicort Respules), nasal sprays (Rhinocort Aqua), and extended-release tablets (Entocort EC, Uceris).
  • How is the effectiveness of budesonide measured in these trials? Effectiveness is measured through various means, including lung function tests (e.g., peak expiratory flow, forced expiratory volume), symptom scores, quality of life assessments, and in some cases, specific disease activity indices like the Pediatric Crohn's Disease Activity Index.
  • Are there any studies comparing different dosages of budesonide? Yes, several studies compare different dosages of budesonide. For example, one study compares Pulmicort Respules at 0.5mg, 1.0mg, and 2.0mg doses, while another compares Rhinocort Aqua nasal spray at 16mg, 32mg, and 64mg per day.
  • Do these trials include both adults and children? Yes, the trials include both adults and children. Some studies focus specifically on pediatric populations, such as children aged 2-8 years with asthma or 5-17 years with Crohn's disease, while others include adolescents and adults.

Ongoing Clinical Trials on Budesonide

  • Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

    Not recruiting

    1 1 1
    Investigated drugs:
    Bulgaria France Germany Ireland Italy Norway +1

  • Study on the Effectiveness of Budesonide and Omeprazole for Treating Crohn’s Disease in the Esophagus, Stomach, or Duodenum in Children

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Poland

  • Study on Budesonide and Poractant Alfa for Preventing Lung Disease in Very Preterm Infants

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Hungary Italy Poland Romania Spain

  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Germany Greece Portugal Slovakia

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol in Patients Aged 40-80 with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    1 1 1
    Investigated drugs:
    Bulgaria Hungary Poland

  • Study on the Effectiveness and Safety of Budesonide and Formoterol Fumarate for Patients with Poorly Controlled Asthma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Spain

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol on Exercise in Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Spain

  • Study on Budesonide Tablets for Preventing Esophageal Narrowing in Adults After Cancer Tissue Removal

    Not recruiting

    1
    Investigated diseases:
    Investigated drugs:
    France Germany The Netherlands Poland Portugal Spain +1

  • Study on the Effects and Safety of Dupilumab for Children Aged 2 to Under 6 with Uncontrolled Asthma or Severe Asthmatic Wheeze

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany Greece Hungary Italy +3

Glossary

  • Budesonide: A corticosteroid medication used to treat various inflammatory conditions such as asthma, allergic rhinitis, and Crohn's disease.
  • Pulmicort Respules: A nebulized suspension form of budesonide used for inhalation treatment of asthma.
  • Pulmicort Turbuhaler: A dry powder inhaler device used to deliver budesonide for asthma treatment.
  • Rhinocort Aqua: A nasal spray formulation of budesonide used to treat allergic rhinitis.
  • Entocort EC: An extended-release capsule form of budesonide used to treat Crohn's disease.
  • Peak Expiratory Flow (PEF): A measure of how quickly a person can exhale air from their lungs, often used to assess asthma severity and control.
  • Forced Expiratory Volume in 1 second (FEV1): The volume of air that can be forcefully exhaled from the lungs in the first second of a forced exhalation, used to assess lung function.
  • Nasal Index Score (NIS): A scale used to measure the severity of nasal symptoms in allergic rhinitis.
  • Pediatric Crohn's Disease Activity Index: A tool used to assess the severity of Crohn's disease in children, with scores ranging from 0 (no disease activity) to 100 (severe disease activity).
  • Bioequivalence: The property of two drug products having the same biological effect and availability in the body when administered at the same dose.

References

  1. https://clinicaltrials.gov/study/NCT01560689
  2. https://clinicaltrials.gov/study/NCT00855959
  3. https://clinicaltrials.gov/study/NCT06245551
  4. https://clinicaltrials.gov/study/NCT00584636
  5. https://clinicaltrials.gov/study/NCT01022047
  6. https://clinicaltrials.gov/study/NCT01444092
  7. https://clinicaltrials.gov/study/NCT01453946
  8. https://clinicaltrials.gov/study/NCT04854538